Mehar S. Manku
Chief Tech/Sci/R&D Officer at Amarin Neuroscience Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark O'Neill | M | - |
Dignity Sciences Ltd.
 Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | - |
| John Climax | M | 71 |
Dignity Sciences Ltd.
Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | - |
| Josephine Coyle | F | - |
Dignity Sciences Ltd.
Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | - |
| Anthony Clarke | M | 68 |
Amarin Neuroscience Ltd.
 Amarin Neuroscience Ltd. Pharmaceuticals: MajorHealth Technology Amarin Neuroscience Ltd. develops pharmaceutical products for depression and neurological disorders. The company was previously known as laxdale Ltd. The company provides clinical supplies of Miraxion through its sub-contractors. The company was founded in 1997 and is headquartered in Stirling, UK. | 19 years |
| Markus H. Weissbach | M | 68 |
Dignity Sciences Ltd.
Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | - |
| Ronan Lambe | M | 84 |
Dignity Sciences Ltd.
Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | - |
| Alan Cooke | M | 52 |
Dignity Sciences Ltd.
Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | - |
| Jane Hollingsworth | F | 66 |
Dignity Sciences Ltd.
Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | - |
| Leopoldo Giampaolo Zambeletti | M | 55 |
Dignity Sciences Ltd.
Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | - |
| David Coughlan | M | - |
Dignity Sciences Ltd.
Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Bodouroglou | M | 69 |
Newcastle University
| 5 years |
| Martin Houston | M | 66 |
Newcastle University
| 4 years |
| Hock Chye Chia | M | 71 |
Newcastle University
| 4 years |
| Paul Roger Fowler | M | 72 |
Newcastle University
| 4 years |
| Neil Pickard | M | - |
Newcastle University
| 4 years |
| Robert Goodwill | M | 67 |
Newcastle University
| 4 years |
| Abdul Azis bin Ariffin | M | 78 |
Newcastle University
| 3 years |
| Chee Wah Tsang | M | 71 |
Newcastle University
| 4 years |
| Boon Keng Teo | M | 70 |
Newcastle University
| 4 years |
| Pandjijono Adijanto | M | 70 |
Newcastle University
| 4 years |
| Chiang Gnee Heng | M | - |
Newcastle University
| 4 years |
| Leigh Berryman | M | - |
Newcastle University
| 4 years |
| David Williams | M | 70 |
Newcastle University
| 4 years |
| Anwar Ali Mustafa Jumabhoy | M | - |
Newcastle University
| 4 years |
| Jeffrey Lindsay | M | - |
Newcastle University
| 4 years |
| Rajiv Wahi | M | - |
Newcastle University
| 3 years |
| Michael Gross | M | - |
Newcastle University
| 3 years |
| Mansour Al Alami | M | 70 |
Newcastle University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 19 | 67.86% |
| Ireland | 9 | 32.14% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mehar S. Manku
- Personal Network
